Estrogen Receptor-dependent and Estrogen Receptor-independent Pathways for Tamoxifen and 4-Hydroxytamoxifen-induced Programmed Cell Death
Open Access
- 1 November 2002
- journal article
- Published by Elsevier BV
- Vol. 277 (47), 45695-45703
- https://doi.org/10.1074/jbc.m208092200
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Molecular Determinants for the Tissue Specificity of SERMsScience, 2002
- Tamoxifen but Not 4-Hydroxytamoxifen Initiates Apoptosis in p53(−) Normal Human Mammary Epithelial Cells by Inducing Mitochondrial DepolarizationPublished by Elsevier BV ,2001
- Cofactor Dynamics and Sufficiency in Estrogen Receptor–Regulated TranscriptionCell, 2000
- A Histone Deacetylase Inhibitor Potentiates Estrogen Receptor Activation of a Stably Integrated Vitellogenin Promoter in HepG2 CellsEndocrinology, 2000
- An APAF-1·Cytochrome c Multimeric Complex Is a Functional Apoptosome That Activates Procaspase-9Published by Elsevier BV ,1999
- Induction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome cCell, 1996
- Role of c-myc in Tamoxifen-Induced Apoptosis in Estrogen-Independent Breast Cancer CellsJNCI Journal of the National Cancer Institute, 1996
- Opposing Effects of ERK and JNK-p38 MAP Kinases on ApoptosisScience, 1995
- Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.The Journal of cell biology, 1992
- Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activationNature, 1980